Rare mutations are helping dangerous hospital bacteria slip past the last-line antibiotic defense
Another last-resort antibiotic has fallen victim to the rapid evolution of drug-resistant superbugs. The powerful antibiotic combination ceftazidime-avibactam (CZA), widely used to treat severe hospital-acquired infections caused by Pseudomonas aeruginosa—particularly in critical
Another last-resort antibiotic has fallen victim to the rapid evolution of drug-resistant superbugs. The powerful antibiotic combination ceftazidime-avibactam (CZA), widely used to treat severe hospital-acquired infections caused by Pseudomonas aeruginosa—particularly in critical This story matters for Science & Discovery readers tracking inventors. Reported by phys.org. Read the full original at the source link below.
Originally reported by phys.org. InventorsNews curates and briefs the science & discovery stories that matter. Our editorial policy →